Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphotransferases (Alcohol Group Acceptor) | 7 | 2018 | 15 | 1.420 |
Why?
|
| Leukemia, Myeloid, Acute | 7 | 2017 | 173 | 1.080 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2016 | 23 | 0.740 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2016 | 2 | 0.600 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2018 | 36 | 0.500 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 141 | 0.480 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2016 | 77 | 0.400 |
Why?
|
| Leukemia, Myeloid | 2 | 2009 | 24 | 0.380 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 320 | 0.370 |
Why?
|
| Neoplastic Stem Cells | 3 | 2017 | 90 | 0.370 |
Why?
|
| Osteopontin | 1 | 2009 | 9 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2005 | 15 | 0.350 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2009 | 95 | 0.340 |
Why?
|
| Signal Transduction | 7 | 2016 | 666 | 0.320 |
Why?
|
| Mice | 12 | 2018 | 2370 | 0.310 |
Why?
|
| Cell Line, Tumor | 8 | 2018 | 681 | 0.310 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 162 | 0.300 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2018 | 113 | 0.280 |
Why?
|
| Loss of Heterozygosity | 2 | 2002 | 17 | 0.280 |
Why?
|
| Cell Survival | 5 | 2016 | 272 | 0.260 |
Why?
|
| Sphingosine | 4 | 2018 | 13 | 0.250 |
Why?
|
| Mice, Inbred NOD | 4 | 2017 | 25 | 0.250 |
Why?
|
| Protein Phosphatase 2 | 2 | 2016 | 5 | 0.240 |
Why?
|
| Breast Neoplasms | 4 | 2008 | 666 | 0.230 |
Why?
|
| Lysophospholipids | 3 | 2018 | 25 | 0.220 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 546 | 0.220 |
Why?
|
| Animals | 13 | 2018 | 7299 | 0.220 |
Why?
|
| Phosphoserine | 3 | 2013 | 5 | 0.210 |
Why?
|
| Humans | 23 | 2019 | 29123 | 0.200 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 136 | 0.190 |
Why?
|
| Cell Membrane | 2 | 2018 | 98 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 249 | 0.180 |
Why?
|
| Caspases | 2 | 2016 | 31 | 0.180 |
Why?
|
| Cell Death | 2 | 2016 | 71 | 0.180 |
Why?
|
| Wrist | 1 | 2019 | 39 | 0.170 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2018 | 1 | 0.170 |
Why?
|
| Wrist Joint | 1 | 2019 | 47 | 0.170 |
Why?
|
| Wrist Injuries | 1 | 2019 | 36 | 0.170 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 114 | 0.170 |
Why?
|
| Survival Analysis | 2 | 2016 | 440 | 0.160 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 8 | 0.160 |
Why?
|
| Head Injuries, Penetrating | 1 | 2017 | 3 | 0.150 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2017 | 1 | 0.150 |
Why?
|
| Benzothiazoles | 1 | 2017 | 4 | 0.150 |
Why?
|
| Naphthyridines | 1 | 2017 | 5 | 0.150 |
Why?
|
| Amino Alcohols | 1 | 2016 | 1 | 0.150 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2016 | 7 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2018 | 143 | 0.150 |
Why?
|
| Wounds, Gunshot | 1 | 2017 | 34 | 0.150 |
Why?
|
| Quinolines | 1 | 2016 | 27 | 0.150 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2016 | 16 | 0.140 |
Why?
|
| Databases, Factual | 1 | 2018 | 332 | 0.140 |
Why?
|
| Pain | 1 | 2019 | 282 | 0.140 |
Why?
|
| Cell Proliferation | 4 | 2018 | 573 | 0.140 |
Why?
|
| Cell Nucleus | 1 | 2016 | 105 | 0.140 |
Why?
|
| Algorithms | 1 | 2019 | 462 | 0.140 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2015 | 2 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2015 | 43 | 0.130 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 52 | 0.130 |
Why?
|
| Female | 8 | 2019 | 18173 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 28 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 39 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2005 | 72 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 3 | 2009 | 158 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 69 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2013 | 1 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 196 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2013 | 31 | 0.120 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2013 | 1 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 4 | 0.120 |
Why?
|
| Apoptosis | 4 | 2018 | 337 | 0.120 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2013 | 8 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2013 | 10 | 0.110 |
Why?
|
| Phosphorylation | 5 | 2013 | 225 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 1219 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 57 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2013 | 436 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 871 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 212 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 301 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2016 | 126 | 0.110 |
Why?
|
| 14-3-3 Proteins | 2 | 2009 | 4 | 0.100 |
Why?
|
| RNA, Neoplasm | 2 | 2009 | 20 | 0.100 |
Why?
|
| Cytokines | 1 | 2013 | 243 | 0.100 |
Why?
|
| Hematologic Neoplasms | 1 | 2011 | 28 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 384 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2008 | 53 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 24 | 0.090 |
Why?
|
| Brain | 1 | 2017 | 930 | 0.090 |
Why?
|
| Cell Line | 4 | 2015 | 450 | 0.090 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2009 | 1 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2009 | 24 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2009 | 514 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 35 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 73 | 0.090 |
Why?
|
| Neurons | 1 | 2013 | 394 | 0.090 |
Why?
|
| Phosphotyrosine | 1 | 2009 | 1 | 0.090 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2009 | 1 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 109 | 0.090 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2006 | 2 | 0.070 |
Why?
|
| F-Box Proteins | 1 | 2005 | 4 | 0.070 |
Why?
|
| Male | 5 | 2019 | 17815 | 0.070 |
Why?
|
| Prognosis | 1 | 2009 | 1362 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2013 | 425 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 249 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2014 | 71 | 0.060 |
Why?
|
| Mutation | 3 | 2015 | 466 | 0.060 |
Why?
|
| Physical Chromosome Mapping | 1 | 2002 | 8 | 0.060 |
Why?
|
| G2 Phase | 2 | 2017 | 14 | 0.060 |
Why?
|
| Cell Growth Processes | 2 | 2014 | 9 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 139 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2002 | 54 | 0.050 |
Why?
|
| Cell Division | 2 | 2017 | 97 | 0.050 |
Why?
|
| Proteins | 1 | 2002 | 140 | 0.050 |
Why?
|
| Binding Sites | 2 | 2015 | 125 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2013 | 799 | 0.050 |
Why?
|
| Aged | 2 | 2010 | 9492 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 836 | 0.040 |
Why?
|
| Models, Biological | 2 | 2013 | 373 | 0.040 |
Why?
|
| Forensic Medicine | 1 | 2017 | 14 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 51 | 0.040 |
Why?
|
| Ceramides | 1 | 2016 | 9 | 0.040 |
Why?
|
| Adult | 1 | 2009 | 8426 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 11 | 0.040 |
Why?
|
| Niacinamide | 1 | 2016 | 8 | 0.040 |
Why?
|
| Protein Transport | 1 | 2016 | 74 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2015 | 4 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2015 | 16 | 0.030 |
Why?
|
| Daunorubicin | 1 | 2015 | 26 | 0.030 |
Why?
|
| Middle Aged | 1 | 2009 | 10834 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 24 | 0.030 |
Why?
|
| Sphingolipids | 1 | 2015 | 1 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 8 | 0.030 |
Why?
|
| Cytarabine | 1 | 2015 | 52 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2015 | 32 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 121 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 76 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 199 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 81 | 0.030 |
Why?
|
| K562 Cells | 1 | 2014 | 4 | 0.030 |
Why?
|
| Genes, myc | 1 | 2014 | 5 | 0.030 |
Why?
|
| Adamantane | 1 | 2014 | 3 | 0.030 |
Why?
|
| Acetylation | 1 | 2014 | 13 | 0.030 |
Why?
|
| Histones | 1 | 2014 | 49 | 0.030 |
Why?
|
| Pyridines | 1 | 2014 | 78 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 332 | 0.030 |
Why?
|
| Hydrazones | 1 | 2013 | 3 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2013 | 14 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2013 | 7 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2013 | 65 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2013 | 70 | 0.030 |
Why?
|
| Propylene Glycols | 1 | 2010 | 2 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 36 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2010 | 34 | 0.020 |
Why?
|
| Mast Cells | 1 | 2009 | 17 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 48 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2008 | 23 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 1604 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 69 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 95 | 0.020 |
Why?
|
| Hela Cells | 1 | 2008 | 78 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2008 | 49 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 204 | 0.020 |
Why?
|
| Serine | 1 | 2006 | 11 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 23 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 18 | 0.020 |
Why?
|
| G1 Phase | 1 | 2005 | 8 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2005 | 4 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 8 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2005 | 17 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 22 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 26 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 32 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 48 | 0.020 |
Why?
|
| Neoplasms | 1 | 2011 | 611 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2005 | 131 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 46 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 486 | 0.010 |
Why?
|